《新股》拨康视云(02592.HK)今起招股 入场费5,100.9元

阿斯达克财经
Jun 24, 2025

临床阶段眼科生物科技公司拨康视云-B(02592.HK)公布在港首次公开发售(IPO)详情,计划全球发售6,058.2万股,当中国际配售部分占90%(5,452.35万股),香港公开发售占10%(605.85万股),发售价为每股10.1元,预料集资近6.12亿元。每手买卖单位500股,入场费约5,100.94元。招股期由今日(24日)起至周五(27日)止,预计会于7月3日挂牌上市。联席保荐人为建银...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10